Oncología médica
Servicio
Curtin University
Perth, AustraliaPublicaciones en colaboración con investigadores/as de Curtin University (3)
2022
-
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer
Clinical Cancer Research, Vol. 28, Núm. 1, pp. 106-115
2018
2016
-
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression
Oncotarget, Vol. 7, Núm. 14, pp. 18325-18345